JR0018

N/A

Report date: 2023/03/03 14:36:48
NME

Base Information

Drug NameJR0018
Drug Alias NameJR0018JR-0018
ClassificationSmall molecules
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsBrain NeoplasmsGliomaLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJingrui Pharmaceutical (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJingrui Pharmaceutical (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsGliomaLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A